OnDemand WTP Pricing Research

Judge axes price disclosure rule for drug ads | Modern Healthcare

The Trump administration cannot force drug manufacturers to disclose prices in their pharmaceutical ads to consumers, a federal judge ruled Monday.

U.S. District Judge Amit Mehta said HHS didn’t have the authority to require drugmakers to publish list prices, a blow to the administration’s strategy to curb pharmaceutical costs. The agency hoped the final rule would boost pharmaceutical price transparency.

Read complete article here: 

Judge axes price disclosure rule for drug ads.

Post a Comment

WP-SpamFree by Pole Position Marketing